Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overview of the DIG trial.

Joseph F Collins1, Debra Egan, Salim Yusuf

  • 1Department of Veterans Affairs, Cooperative Studies Program, Perry Point, Maryland 21902, USA. joseph.collins2@med.va.gov

Controlled Clinical Trials
|December 4, 2003
PubMed
Summary

The Digitalis Investigation Group (DIG) trial found digoxin did not significantly affect overall mortality in heart failure patients. However, it did impact hospitalization rates, highlighting its role in managing heart failure symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 outcomes and persistent symptoms in patients with hypertrophic cardiomyopathy: association with pre-existing cardiovascular magnetic resonance phenotype.

Heart (British Cardiac Society)·2026
Same author

Pharmacokinetics, Safety, and Tolerability of Anti-miR-17 Oligonucleotide RGLS4326 in Healthy Adult Subjects.

Journal of clinical pharmacology·2026
Same author

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

JAMA·2026
Same author

Relationship between Total Kidney Volume and eGFR in Autosomal Dominant Polycystic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinoma.

Nature cancer·2026
Same author

CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study.

Blood advances·2025

Area of Science:

  • Cardiology
  • Clinical Trials
  • Public Health

Background:

  • Congestive heart failure (CHF) presents a significant public health challenge in Western nations.
  • Effective management strategies for CHF are crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of digoxin in reducing all-cause mortality in patients with heart failure.
  • To assess the impact of digoxin on hospitalization rates for heart failure.

Main Methods:

  • The Digitalis Investigation Group (DIG) trial was a large-scale, randomized, double-blind, placebo-controlled study.
  • 6800 patients with heart failure (left ventricular ejection fraction ≤0.45) and normal sinus rhythm were enrolled.
  • Participants were recruited from 302 centers across the US and Canada over 31.5 months and followed for at least 28 months.

Related Experiment Videos

Main Results:

  • Digoxin did not demonstrate a significant reduction in all-cause mortality.
  • The study provided insights into the drug's effect on heart failure hospitalizations.

Conclusions:

  • Digoxin's role in managing heart failure requires careful consideration of its impact on mortality and hospitalization.
  • The successful execution of the DIG trial underscores the feasibility of large simple trials in cardiovascular research.